Related Experiment Video
Updated: Jun 6, 2025

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
Published on: September 30, 2021
Deconstructing the ISTH hemophilia guidelines for the clinician
Guy Young1, Riitta Lassila2, Jane Mason3
1Cancer and Blood Disorders Institute, Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, California, USA.
Insights
The International Society on Thrombosis and Haemostasis (ISTH) released new hemophilia guidelines, but many recommendations are conditional. This analysis offers clinicians more concrete guidance for managing hemophilia patients.
Area of Science:
- Hematology
- Clinical Guidelines
- Rare Diseases
Background:
- The International Society on Thrombosis and Haemostasis (ISTH) recently published comprehensive hemophilia guidelines.
- These guidelines, while valuable, present numerous conditional recommendations, offering limited concrete direction for clinicians.
- The reliance on the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) methodology for a rare disease like hemophilia contributes to the conditional nature of the recommendations.
Purpose of the Study:
- To deconstruct the ISTH hemophilia guidelines and provide clinicians with more actionable recommendations.
- To supplement the ISTH guidelines with recent literature and expert clinical experience.
- To offer a clearer path forward for managing patients with hemophilia.
Main Methods:
- Critical analysis of the published ISTH Hemophilia Guidelines.
- Integration of recent scientific literature relevant to hemophilia management.
- Incorporation of extensive clinical experience from managing diverse hemophilia patient populations.
Main Results:
- Identified that 11 out of 13 ISTH recommendations are conditional, requiring individual clinical judgment.
- Developed a supplementary framework to provide more definitive management strategies.
- Synthesized current evidence and expert opinion to address ambiguities in the guidelines.
Conclusions:
- The ISTH guidelines require further interpretation to provide practical clinical application.
- Clinicians need supplementary resources to navigate the conditional nature of hemophilia treatment recommendations.
- This work offers a more concrete approach to hemophilia patient care, balancing guidelines with real-world experience and evidence.
Abstract:
Recently, the International Society on Thrombosis and Haemostasis (ISTH) Hemophilia Guidelines were published in this journal. The authors of these guidelines should be commended for a herculean task that took years to complete, and while this is no doubt a welcome addition to the literature, it does leave many questions for the clinician. This is primarily because 11 of the 13 recommendations are conditional, essentially meaning "that clinicians and patients need to consider individual preferences as well as the specific circumstances in which the decision is being made for implementation of the recommendation." So, in essence, most of the recommendations allow the clinician to decide whether to use them or not. In our view, most clinicians are seeking more concrete recommendations when they search for a guidelines paper. Unfortunately, numerous conditional recommendations have been developed because hemophilia is a rare disease and the ISTH Guidelines rely upon the Grading of Recommendations, Assessment, Development, and Evaluation methodology. We endeavored to "deconstruct" the ISTH recommendations and offer clinicians a more concrete path forward based in part on the guidelines but supplemented with more recent literature and our own extensive experience and perspective managing hemophilia patients of all ages from 4 continents.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...

